Early Supplier Involvement (ESI) is proving to be invaluable because of market globalization and increased pressure to commercialize innovations at a faster pace.

In the medical industry, breakthrough innovations are emerging at an unprecedented rate. In fact, at no point in the history of medical devices and clinical research has so much changed so fast. This is having a profound impact on how OEMs approach their work.

To stay competitive, OEMs must rethink how they create and commercialize their new technologies. Being creative in their processes is critical to innovating effectively.

Early Supplier Involvement has long been a strategy employed by manufacturers to produce innovative products. Now, it almost seems like a necessity. Because decisions made in the design phase can positively affect product quality and costs, this can help add value to OEM bottom lines.

This white paper will discuss many facets of ESI, including why it’s so valuable today, what challenges limit the benefits of ESI, how cost is impacted, and more.

To download, please complete the form on this page. Your download is sponsored by Parker Hannifin.